Fountainheadinvesting

Categories
Insurance

Globe Life (GL): A Speculative Play on Short Covering and Market Reactions

This is a speculative trade article from an analyst on Seeking Alpha, looking for a short covering bounce, so keep that in mind, when you make your decision.

Globe Life did get a positive report this morning from an analyst, Edward Vranic on Seeking Alpha, suggesting that there would be enough short covering and likely winding up of the speculator’s positions, since they have achieved their short target of $64.

Like most professional short sellers Fuzzy Panda, has used all the alleged corrupt practices at Globe Life to paint a negative picture. As the analyst writes, they didn’t compare it to Primerica, which has a similar problem, and this could be an industry problem.

  • Policies Written for Dead and Fictitious People. 
  • Forged Signatures. 
  • Funds Withdrawn from Consumers’ Bank Accounts without Approval
  • Fictitious Bank Accounts are used to Fund Numerous Fake Policies, so Agents hit their bonuses.

Quoting from the report

  • Fuzzy Panda held a $64.35 price target. GL has dropped below that mark.
  • GL now has valuation metrics well below the industry average and significantly below PRI, it’s most directly comparable as a life insurance company with an MLM sales structure.
  • I believe that the stock price will bounce back to $80 or higher due to short sellers covering their positions and bullish investor speculation.
  • What Fuzzy Panda managed to do was paint GL as a dysfunctional organization filled with frat boys and “crypto bro” types that undertake aggressive sales tactics, show off online, and engage in perverse and questionable behaviors. What it didn’t do is assess how much of this is outside of an industry standard. It wouldn’t be the first time that 25-year-old men out of college bragged about their $100,000 cars, and the company leveraged that as a recruitment tactic. Isn’t the whole point of a growing company to make itself appealing? Should GL be punished for being more honest and upfront about the type of people it believes will do well in selling insurance at its company? If there is something wrong with it, then where are the regulators? Not just over the past five years, for when Fuzzy Panda believes this behavior at GL has accelerated. But over the last 100 years, when a rich lifestyle and fast cars as a financial products sales guru was portrayed as an American dream.
  • The behaviors undertaken by certain employees and management teams of life insurance companies have been unfortunate. However, up until today – and even in the case of GL up until April 11th – few people on Wall Street cared. For whatever reason, the market reaction was quite pronounced on Fuzzy Panda’s report. Even though it was essentially an aggregation of previously disclosed and/or publicly accessible information along with the opinion of a handful of self-proclaimed experts and investigators. I think that reaction went too far, leading to a speculative buying opportunity on GL.
  • Fuzzy Panda and associates will cover their shorts. Short interest was 2.75 million as of March 28th and short-marked volume was over 2.2 million between that date and April 10th. It was over 5 million on April 11th, the day of the report. Some shorts are likely already covered on April 12th. One report shows that a significant put option position was opened, and then closed on the 11th. I believe that momentum will continue into this week as the remaining shorts who shorted high will take their profits, while those who are late to the game and entered in at a low price will be squeezed. I remind readers that Fuzzy Panda’s “generous” target was $64.35. Unlike other short reports I have seen, it did not quantify an impact of any potential restatements of financials nor come up with a target of $0 or close to it. Given the relative softness in terms of price targets compared to other reports I have seen, I believe that this firm will be more likely to take profits than to push the narrative for more gains at a lower price.
  • Therefore, $80 is a reasonable near-term speculative price target on GL and I have positioned myself accordingly.

Here is the link if you want to read the full article.

https://seekingalpha.com/article/4683754-globe-life-betting-on-a-bounce-to-80

Categories
Insurance Stocks

Globe Life (GL): Navigating Short Selling Allegations and Market Volatility

Globe Life (GL) $53

Category – Financial Services – subcategory- insurance

There is a short-selling operation going on by Orso Partners, alleging insurance fraud and of course the usual denials, and the short covering, which caused the 10% bounce premarket.

https://www.cnbc.com/2024/04/11/globe-life-shares-plummet-50percent-after-short-seller-accuses-company-of-insurance-fraud.html

Historically, though higher mortality rates, mostly pandemic related, was one of the main reasons for the drop in 2022 income.

While the balance sheet is relatively OK, debt levels are elevated, which is not ideal in a high-interest rate environment. 

There is a lot depending on declining or increasing mortality rates, and this could cause a lot of volatility in its stock.

That said, the company and analyst estimates are calling for 8% earnings growth in the next 3 years, and if the fraud claims are bogus and just short seller manipulation, the valuation is quite good. It has been a profitable company in the last 5-7 years.

But without enough information on the validity of Orso’s fraud claim it would be difficult to make a call. 

Categories
Insurance

Globe Life (GL): Navigating Short Selling Allegations and Market Volatility

Globe Life (GL) $53

There is a short selling operation going on by Orso Partners, who’re alleging insurance fraud and of course the usual denials, and the short covering, which caused the 10% bounce premarket.

https://www.cnbc.com/2024/04/11/globe-life-shares-plummet-50percent-after-short-seller-accuses-company-of-insurance-fraud.html

Historically, though higher mortality rates, mostly pandemic related, was one of the main reasons for the drop in 2022 income.

While the balance sheet is relatively OK, debt levels are elevated, which, in a high-interest rate environment, is not ideal. 

There is a lot depending on declining or increasing mortality rates, and this could cause a lot of volatility in its stock.

That said, the company and analyst estimates are calling for 8% earnings growth in the next 3 years, and if the fraud claims are bogus and just short seller manipulation, the valuation is quite good. It has been a profitable company in the last 5-7 years.

But without enough information on the validity of Orso’s fraud’s claim it would be difficult to make a call.